Harvard Bioscience (HBIO) Non Operating Interest Expenses (2010 - 2019)

Harvard Bioscience (HBIO) has reported Non Operating Interest Expenses for 10 consecutive years, with $1.3 million the latest figure, recorded in Q3 2019.

• On a quarterly basis, Non Operating Interest Expenses fell 7.54% year-over-year to $1.3 million in Q3 2019; TTM through Sep 2019 was $5.7 million, a 40.96% increase from a year earlier, with the FY2018 full-year figure at $5.4 million, up 652.73% from the prior year.
• Non Operating Interest Expenses was $1.3 million for Q3 2019 at Harvard Bioscience, down from $1.4 million in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $1.5 million in Q4 2018 and troughed at $141000.0 in Q3 2016.
• A 5-year average of $615526.3 and a median of $205000.0 in 2015 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses sank 30.88% in 2016 and soared 746.41% in 2018, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at $205000.0 in 2015, then decreased by 24.39% to $155000.0 in 2016, then grew by 16.77% to $181000.0 in 2017, then soared by 746.41% to $1.5 million in 2018, then fell by 12.01% to $1.3 million in 2019.
• The last three Non Operating Interest Expenses figures came in at $1.3 million (Q3 2019), $1.4 million (Q2 2019), and $1.4 million (Q1 2019), per Business Quant data.